Prevention of Heart Disease
 
The following citations are divided into five categories; General, Heart Failure, Nutriton, Stress, Viral Infection and Books.

General

  1. Finlayson R.  Ischaemic heart disease, aortic aneurysms, and atherosclerosis in the City of London, 1868-1982.   Med Hist Suppl. 1985; (5): 151-68. Abstract   [1868 to 1900 there were almost no deaths from MI]
  2. Herrick JB.  Clinical Features of Sudden Obstruction of the Coronary Arteries. [Six cases of coronary thrombosis: the first report that was taken seriously]   JAMA 1912; 59; 2015  No web link available.
  3. MacKinnon AU.  The origin of the modern epidemic of coronary artery disease in England.   J R Coll Gen Pract. 1987 Apr;37(297):174-6. Abstract   [1868 to 1900 there were almost no deaths from MI]
  4. Martin, W.  The Prudent Heart Diet and Cholesterol Lowering Drugs: Why They Don’t Prevent Heart Disease   Townsend Letter for Doctors & Patients  2002, Aug-Sept.   Full text 
  5. Martin, W.  Reducing Deaths from Heart Attacks and Cancer Full text 
  6. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: quantitative review of primary prevention trials. British J Med, 1990; 301: 309-314   Abstract
  7. Newman TB, Hulley SB: Carcinogenicity of lipid lowering drugs. JAMA 1996: Jan3: 275: 55-60    Abstract 
  8. Oz MC, Lemole EJ, Oz LL, Whitworth GC, Lemole GM.  Treating CAD with Cardiac Surgery Combined with Complementary Therapy.  Medscape Womens Health. 1996 Oct; 1(10): 7   Abstract |  Full text 

Heart Failure

  1. Berman M, Erman A, Ben-Gal T,et al.   Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.   Clin Cardiol. 2004 May; 27(5): 295-9.  Abstract 
  2. Hargreaves IP.   Ubiquinone: cholesterol's reclusive cousin. Ann Clin Biochem. 2003 May; 40(Pt 3): 207-18.  Abstract 
  3. Langsjoen PH, Langsjoen AM.  The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications.   Biofactors. 2003; 18(1-4): 101-11.  Abstract 
  4. Mortensen SA.  Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.   Biofactors. 2003; 18(1-4): 79-89. Abstract 
  5. Rosenfeldt F, Hilton D, Pepe S, Krum H.  Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure.Biofactors. 2003; 18(1-4): 91-100.  Abstract 
  6. Tran MT, Mitchell TM, Kennedy DT, Giles JT.  Role of coenzyme Q10 in chronic heart failure, angina, and hypertension.   Pharmacotherapy. 2001 Jul; 21(7): 797-806. Abstract 

Nutrition

  1. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Lalouschek W, Ahmadi R, Minar E, Schillinger M.  Low serum magnesium predicts neurological events in patients with advanced atherosclerosis.   Stroke. 2004 Jan; 35(1): 22-7 Abstract
  2. Berger MM, Mustafa I.  Metabolic and nutritional support in acute cardiac failure.   Curr Opin Clin Nutr Metab Care. 2003 Mar; 6(2): 195-201  Abstract 
  3. Bordia A, Verma SK. Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients.  Clin Cardiol. 1985 Oct; 8(10): 552-4.  Abstract 
  4. Brown DJ, Goodman J. A review of vitamins A, C, and E and their relationship to cardiovascular disease.  Clin Excell Nurse Pract. 1998 Jan; 2(1): 10-22  Abstract 
  5. Chapidze G, Kapanadze S, Dolidze N, et al.  Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.   Georgian Med News. 2005 Jan; (1): 20-5.  Abstract 
  6. Chung MK.  Vitamins, supplements, herbal medicines, and arrhythmias.Cardiol Rev. 2004 Mar-Apr; 12(2): 73-84.  Abstract 
  7. Church TS, Earnest CP, Wood KA, Kampert JB.  Reduction of C-reactive protein levels through use of a multivitamin.    Am J Med. 2003 Dec 15; 115(9) :702-7  Abstract 
  8. Crestanello JA, Doliba NM, Doliba NM, et al.  Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion.   J Surg Res. 2002 Feb; 102(2): 221-8. Abstract 
  9. Cristina Polidori M, Pratico D, Savino K, Rokach J, Stahl W, Mecocci P. Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity.  J Card Fail. 2004 Aug; 10(4): 334-338. Abstract 
  10. Delarue J, Matzinger O, Binnert C, Schneiter P, Chiolero R, Tappy L. Fish oil prevents the adrenal activation elicited by mental stress in healthy men.   Diabetes Metab. 2003 Jun; 29(3): 289-95 Abstract
  11. Din JN, Newby DE, Flapan AD.  Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment.   BMJ. 2004 Jan 3; 328(7430): 30-5   Full text 
  12. Elsherif L, Jiang Y, Saari JT, Kang YJ. et al.  Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion.   Exp Biol Med (Maywood). 2004 Jul; 229(7): 616-22.  Abstract 
  13. Flader D, Brandsch C, Hirche F, Eder K. Effects of megadoses of dietary vitamin E on the antioxidant status of rats fed lard or salmon oil. Int J Vitam Nutr Res. 2003 Jul; 73(4): 275-83   Abstract 
  14. Foster GD, Wyatt HR, Hill JO, et al.  A randomized trial of a low-carbohydrate diet for obesity.  N Engl J Med. 2003 May 22; 348(21): 2082-90. Abstract 
  15. Genova ML, Pich MM, Bernacchia A, et al.  The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann N Y Acad Sci. 2004 Apr; 1011: 86-100. Abstract 
  16. Gums JG.  Magnesium in cardiovascular and other disorders.Am J Health Syst Pharm. 2004 Aug 1; 61(15): 1569-76.  Abstract 
  17. Hays JH, DiSabatino A, Gorman RT, Vincent S, Stillabower ME.  Effect of a high saturated fat and no-starch diet on serum lipid subfractions in patients with documented atherosclerotic cardiovascular disease. Mayo Clin Proc. 2003 Nov; 78(11): 1331-6.  Abstract 
  18. Hirsch S, Pia De la Maza M, Yanez P, Glasinovic A, Petermann M, Barrera G, Gattas V, Escobar E, Bunout D.  Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation. Clin Cardiol. 2002 Nov; 25(11): 495-501.   Abstract 
  19. Hoffer A. Editorial: The True Cost of Cynicism.   J Orthomolecular Med 1992; 7(4)  Full Text 
  20. Horrocks LA, Yeo YK.  Health benefits of docosahexaenoic acid (DHA)Pharmacol Res. 1999 Sep; 40(3): 211-25.  Abstract 
  21. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study.  Lancet. 2001 Mar 3; 357(9257): 657-63   Abstract 
  22. Klevay LM.  Ischemic heart disease as deficiency disease. Cell Mol Biol (Noisy-le-grand). 2004 Dec; 50(8): 877-84. Abstract 
  23. Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC.  Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration.  Nutrition. 2003 Jul-Aug; 19(7-8): 577-83.  Abstract 
  24. Lee KW, Lip GY.  The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease.   QJM. 2003 Jul; 96(7): 465-80  Abstract 
  25. Li D.  Omega-3 fatty acids and non-communicable diseases. Chin Med J (Engl). 2003 Mar; 116(3): 453-8   Abstract |  Full text 
  26. Libby P, Aikawa M.  Vitamin C, collagen, and cracks in the plaque. Circulation. 2002 Mar 26; 105(12): 1396-8.  Full text 
  27. McFarlane SI, Muniyappa R, Shin JJ, et al.  Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?  Endocrine. 2004 Feb; 23(1): 1-10.  Abstract 
  28. [No authors listed]  Thiamine.  Altern Med Rev. 2003 Feb; 8(1): 59-62   Full text 
  29. O'Keefe JH Jr, Cordain L. Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer.   Mayo Clin Proc. 2004 Jan; 79(1): 101-8. Abstract 
  30. Ornish D, Brown SE, Scherwitz LW, et al.  Can lifestyle changes reverse coronary heart disease?    Lancet. 1990 Jul 21;336(8708):129-33.  Abstract 
  31. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, et al.  Vitamin C and risk of coronary heart disease in women.    J Am Coll Cardiol. 2003 Jul 16; 42(2): 246-52.  Abstract 
  32. Panagiotakos DB, Pitsavos C, Zampelas A, et al. Fish consumption and the risk of developing acute coronary syndromes: the CARDIO2000 study. Int J Cardiol. 2005 Jul 20; 102(3): 403-9.  Abstract 
  33. Pauling, Linus & Rath, Matthias   A Unified Theory of Human Cardiovascular Disease Leading the Way to the Abolition of This Disease as a Cause for Human Mortality.   J Orthomolecular Med 1995; 7(1)  Full text 
  34. Pelkman CL, Fishell VK, Maddox DH, Pearson TA, Mauger DT, Kris-Etherton PM. Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women.   Am J Clin Nutr. 2004; 79: 204-212  Abstract 
  35. Price KD, Price CS, Reynolds RD.  Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis.   Atherosclerosis. 2001 Sep; 158(1): 1-12. Abstract 
  36. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men.    N Engl J Med. 1993 May 20; 328(20): 1450-6  Abstract 
  37. Rosenfeldt F, Marasco S, Lyon W, et al.  Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.   J Thorac Cardiovasc Surg. 2005 Jan; 129(1): 25-32.  Abstract 
  38. Rosenfeldt F, Miller F, Nagley P, Hadj A, Marasco S, Quick D, Sheeran F, Wowk M, Pepe S.  Response of the senescent heart to stress: clinical therapeutic strategies and quest for mitochondrial predictors of biological age.  Ann N Y Acad Sci. 2004 Jun; 1019: 78-84. Abstract 
  39. Rosenfeldt FL, Pepe S, Linnane A, et al. The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium.Biogerontology. 2002; 3(1-2): 37-40.  Abstract 
  40. Severus WE, Littman AB, Stoll AL.  Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder.  Harv Rev Psychiatry. 2001 Nov-Dec; 9(6): 280-93. Abstract |  Full text 
  41. Simon JA, Hudes ES.  Relation of serum ascorbic acid to serum lipids and lipoproteins in US adults.   J Am Coll Nutr. 1998 Jun; 17(3): 250-5.   Abstract |  Full text 
  42. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids.   Biomed Pharmacother. 2002 Oct; 56(8): 365-79 Abstract 
  43. Sole MJ, Jeejeebhoy KN.  Conditioned nutritional requirements: therapeutic relevance to heart failure.  Herz. 2002 Mar; 27(2): 174-8. Abstract 
  44. Swamidas GP, Basaraba RJ, Baybutt RC.  Dietary retinol inhibits inflammatory responses of rats treated with monocrotaline.  J Nutr. 1999 Jul;129(7):1285-90 Abstract |  Full text 
  45. Tawakol A, Migrino RQ, Aziz KS, et al.  High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease.   J Am Coll Cardiol. 2005 May 17; 45(10): 1580-4.  Abstract 
  46. Ueshima K.  [Magnesium and ischemic heart disease]  Clin Calcium. 2005 Feb; 15(2): 175-80. Abstract 
  47. Wilburn AJ, King DS, Glisson J, Rockhold RW, Wofford MR.  The natural treatment of hypertension.   J Clin Hypertens (Greenwich). 2004 May; 6(5): 242-8   Abstract 
  48. Witte KK, Clark AL, Cleland JG.  Chronic heart failure and micronutrients.J Am Coll Cardiol. 2001 Jun 1; 37(7): 1765-74.  Abstract 
  49. Zampelas A, Panagiotakos DB, Pitsavos C, et al.  Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study.  J Am Coll Cardiol. 2005 Jul 5; 46(1): 120-4.  Abstract 

Stress

  1. Astin JA, Shapiro SL, Eisenberg DM, Forys KL.  Mind-body medicine: state of the science, implications for practice.   J Am Board Fam Pract. 2003 Mar-Apr; 16(2): 131-47  Abstract  |  Full text 
  2. Bigert C, Gustavsson P, Hallqvist J, Hogstedt C, Lewne M, Plato N, et al. Myocardial infarction among professional drivers.   Epidemiology. 2003 May; 14(3): 333-9   Abstract 
  3. Chaput LA, Adams SH, Simon JA, Blumenthal RS, Vittinghoff E, Lin F, Loh E, Matthews KA.  Hostility predicts recurrent events among postmenopausal women with coronary heart disease.   Am J Epidemiol. 2002 Dec 15; 156(12): 1092-9.  Abstract  |  Full text 
  4. Denollet J, Brutsaert DL.  Reducing emotional distress improves prognosis in coronary heart disease: 9-year mortality in a clinical trial of rehabilitation.   Circulation. 2001 Oct 23; 104(17): 2018-23   Abstract  |  Full text 
  5. Denollet J, Vaes J, Brutsaert DL.  Inadequate response to treatment in coronary heart disease : adverse effects of type D personality and younger age on 5-year prognosis and quality of life.  Circulation. 2000 Aug 8; 102(6): 630-5  Abstract  |  Full text 
  6. Eaker ED, Sullivan LM, Kelly-Hayes M, et al.  Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality:   Psychosom Med. 2005 Sep-Oct; 67(5): 692-6.  Abstract 
  7. Egolf B, Lasker J, Wolf S, Potvin L. The Roseto effect: a 50-year comparison of mortality rates. Am J Public Health. 1992 Aug; 82(8): 1089-92. Abstract 
  8. Friedman M, Thoresen CE, Gill JJ,  et al.  Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project.Am Heart J. 1986 Oct; 112(4): 653-65.  Abstract 
  9. Ghiadoni L, Donald AE, Cropley M, et al.  Mental stress induces transient endothelial dysfunction in humans.  Circulation. 2000 Nov 14; 102(20): 2473-8.  Abstract  |  Full text 
  10. Hemingway H, Marmot M.  Evidence-based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 1999; 318: 1460-1467 Full text 
  11. Kawakami N, Akachi K, Shimizu H,  et al.   Job strain, social support in the workplace, and haemoglobin A1c in Japanese men.Occup Environ Med. 2000 Dec; 57(12): 805-9  Abstract 
  12. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al.   Chronic stress and age-related increases in the proinflammatory cytokine IL-6.Proc Natl Acad Sci U S A. 2003 Jul 22; 100(15): 9090-5  Abstract  |  Full text 
  13. Lasker JN, Egolf BP, Wolf S.  Community social change and mortality.Soc Sci Med. 1994 Jul; 39(1): 53-62.   Abstract 
  14. Lavie CJ, Milani RV.  Prevalence of hostility in young coronary artery disease patients and effects of cardiac rehabilitation and exercise training.  Mayo Clin Proc. 2005 Mar; 80(3): 335-42. Abstract 
  15. Panagiotakos DB, Chrysohoou Ch, Pitsavos Ch, et al.  The association between occupational stress and the risk of developing acute coronary syndromes: the CARDIO2000 Study.  Cent Eur J Public Health. 2003 Mar; 11(1): 25-30  Abstract 
  16. Pickering T, Clemow L, Davidson K, Gerin W.  Behavioral cardiology --has its time finally arrived?   Mt Sinai J Med. 2003 Mar; 70(2): 101-12  Abstract | Full text 
  17. Pitsavos C, Panagiotakos DB, Papageorgiou C, et al.  Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study.   Atherosclerosis. 2005 Jul 7 Abstract 
  18. Rosenman RH, Friedman M.  The possible relationship of occupational stress to clinical coronary heart disease.  Calif Med. 1958 Sep; 89(3): 169-74  Abstract 
  19. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-2217    Abstract  | Full text 
  20. Tennant CC, McLean L.   Mood disturbances and coronary heart disease: progress in the past decade    MJA 2000; 172: 151-152 Full text 
  21. Tennant CC, Palmer KJ, Langeluddecke PM, et al. Life event stress and myocardial reinfarction: a prospective study.   Eur Heart J 1994; 15: 472-478. Abstract 
  22. WebMD/Lycos - Article - Hostility Predicts Heart Disease Full text 
  23. Wolf S.  Visceral responses to the social environment. Acta Physiol Scand Suppl. 1997; 640: 140-3.   Abstract 
  24. Wolf S.  Predictors of myocardial infarction over a span of 30 years in Roseto, Pennsylvania  Integr Physiol Behav Sci. 1992 Jul-Sep; 27(3): 246-57.   Abstract 

Viral Infections

  1. Ahn J, Joo CH, Seo I,  et al. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol. 2005 Feb; 75(2): 290-4.   Abstract 
  2. Chu PL, Chang WT, Chen WJ, Chen YS.  Acute viral myocarditis presenting as sudden cardiac arrest and refractory ventricular tachycardia. Am J Emerg Med. 2004 Nov; 22(7): 628-9.  Full text 
  3. Cioc AM, Nuovo GJ.  Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death.   Mod Pathol. 2002 Sep; 15(9): 914-22.  Abstract 
  4. Fujioka S, Kitaura Y, Deguchi H, et al.   Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy.   Am J Cardiol. 2004 Sep 1; 94(5): 602-5.   Abstract 
  5. Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A.  Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy.   J Am Coll Cardiol. 2000 Nov 15; 36(6): 1920-6.  Abstract 
  6. Kyto V, Vuorinen T, Saukko P, et al.  Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.  Clin Infect Dis. 2005 Mar 1; 40(5): 683-8.  Abstract | Full text 
  7. Nicholls AC, Thomas M.  Coxsackie virus infection in acute myocardial infarction.   Lancet. 1977 Apr 23; 1(8017): 883-4. Abstract 
  8. Pankuweit S, Lamparter S, Funck R, Maisch B. [Endomyocardial biopsy-guided diagnosis and treatment of inflammatory cardiomyopathies]  Dtsch Med Wochenschr. 2004 Oct 8; 129(41): 2169-72.  Abstract 
  9. Wang X, Zhang G, Liu F, et al.  Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.  J Clin Virol. 2004 Sep; 31(1): 20-4.  Abstract 

Books

Type A behavior and Your Heart.   Meyer Friedman & Ray H. Rosenman, MDs, 1974 

Treating Type A behavior and Your Heart.   Meyer Friedman, M.D. & Diane Ulmer, 1984 
Heart Disease.   Paul Dudley White, M.D.   The MacMillan Co. 1931, pp 295-304
Heart Disease.   Paul Dudley White, M.D.  The MacMillan Co. 1943
Vitamin E for Ailing and Healthy Hearts.  Wilfred E. Shute, M.D.  Pyramid House Books.  1970

Print this page

Home